Dr. Karen Kim, dean of the College of Medicine, speaks at the Research and Innovation Awards on April 30. Kim recently briefed the Penn State Board of Trustees Committee on Academic Affairs, Research and Student Life on the College of Medicine’s strategies related to artificial intelligence.
Penn State’s Board of Trustees Committee on Academic Affairs, Research and Student Life discussed the university’s artificial intelligence portfolio and strategies to build on the current intelligence footprint (AI) University at its June 20 committee meeting.
July 2, 2024
The committee members who joined were Dr Karen Kimdean of the Faculty of Medicine, and Dajiang LiuDistinguished Professor and Vice Chair for Research in the Department of Public Health Sciences and Director of Bioinformatics and Artificial Intelligence. Together, they highlighted how the College is poised to become a leader in the AI revolution by taking full advantage of scientific, technological and practical applications to improve health.
“The College of Medicine, along with our health system, Penn State Health, is uniquely positioned to advance AI at the intersection of health and technology,” Kim said. “Through our vast data resources and exceptional faculty, we are reimagining biomedical research, education, health outcomes and value-based patient care. »
Kim outlined the College of Medicine’s strategies for leveraging AI along four lines:
- Maximize patient outcomes with predictive health models and equitable AI applications to improve the future of health
- Reimagining the role of AI in advancing scientific discovery
- Using AI to Improve Operational Efficiency and Streamline Work for Faculty and Staff
- Reduce administrative workloads using AI to improve administrative efficiency in a cost-effective manner
“As the only rural academic health system in Pennsylvania and the only land-grant university in the Commonwealth, we use data to improve the lives of our community members,” Kim said.
Studying artificial intelligence to improve health outcomes
AI continues to be a strategic priority at the College of Medicine. In 2023, the the college provided pilot funding to support AI projects. Professors leveraged this initial investment to continue their research.
Within the Faculty of Medicine, researchers participate in projects related to the use of artificial intelligence with various objectives, including the identification of risk factors to provide better preventive medicine, preventing the recurrence of health events major health issues or provide earlier and more accurate diagnosis of health problems. Here are some examples:
- Join a national consortium of researchers to use artificial intelligence to improve the accuracy and timing of autoimmune disease diagnosis. Early diagnosis of autoimmune diseases will improve treatment.
- Develop a multi-center validated AI model to predict mortality and prevent recurrence of stroke.
- To be a funded site to use data science methods to study mechanisms of chronic obstructive pulmonary disease specific to women as part of the National Institute of Health’s initiative to improve women’s health research.
- Using AI algorithms to identify new treatments for autoimmune disease And addictive behaviors.
In addition to using the expertise of researchers and clinicians at the College of Medicine and Penn State Health for artificial intelligence projects, the college works across Penn State and Commonwealth campuses and partners with Highmark Health to leverage data science to optimize predictive models and patient outcomes. .
“The Faculty of Medicine was committed to making artificial intelligence a research priority long before it became a buzzword,” Liu said. “Our expert interdisciplinary faculty have the tools and motivation to make our research nationally competitive. I look forward to our progress and the future.
If you are having difficulty accessing this content or would like to view it in another format, please email Penn State Health Marketing and Communications.